A microRNA-based diagnostic assay distinguishes squamous from non-squamous non small-cell lung carcinoma
Danit Lebanony(Rosetta Genomics (Israel)), Mahesh Mansukhani(Columbia University Irving Medical Center), Jingyao Zhong(Columbia University Irving Medical Center), Ranit Aharonov(Unknown), Nitzan Rosenfeld(Queen Mary University of London), Yael Spector(Rosetta Genomics (Israel)), Ayelet Chajut(Rosetta Genomics (Israel)), Daisuke Nonaka(University of Maryland, Baltimore), Harvey I. Pass(NYU Langone Health), Dalia Cohen(Regulus Therapeutics (United States)), Hila Benjamin(Rosetta Genomics (Israel)), Shlomit Gilad(Rosetta Genomics (Israel))
Clinical Cancer Research
October 1, 2008
Cited by 0
Related Papers
Liquid biopsies come of age: towards implementation of circulating tumour DNA
|Nature reviews. Cancer|2017|2.6k
The somatic mutation profiles of 2,433 breast cancers refine their genomic and transcriptomic landscapes
|Nature Communications|2016|1.8k
Dynamics of the p53-Mdm2 feedback loop in individual cells
|Nature Genetics|2004|1k
MicroRNAs accurately identify cancer tissue origin
|Nature Biotechnology|2008|987
Oscillations and variability in the p53 system
|Molecular Systems Biology|2006|659